DB Power and LPA announce strategic partnership to globally expand solutions for issuers of structured retail products

Real Time Search
CES A80 :
CES HKMI :
CES 120 :
Total Turn.

01541 IMMUNEONCO-B

Trading Add to Porfolio
Index Constituent : None
Major Shareholders Tian Wenzhi & Associates (28.49%)
Yu Xiaoyong & Associates (9.21%)
Sector Health Care & Biotechnology
Web Site http://www.immuneonco.com Tel (86 21) 3801-6387
Email info@immuneonco.com Fax N/A
Related Equities N/A
Principal Activities The Group is a science-driven biotechnology group dedicated to the development of immuno-oncology therapies.

Consolidated List of Substantial Shareholders

Name Number of Shares Interested % of Issued Share Capital (%) Date of Last Notice Filed (Y/M/D)
Last Update :
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool

Complete List of Directors

Director's Name Number of Shares Interested % of issued share capital (%) Date of Last Notice Filed (Y/M/D)
Last Update :
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool
Back to Top